Oliveda International, Inc. (OLVI)
USD 2.98
(14.62%)
USD 2.98
(14.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -139.62 Thousand | 1933.00 | -1.96 Million | 4.01 Million | -200.68 Thousand | 44.74 Thousand |
| Net Income | -1.3 Million | 1.44 Million | 636.75 Thousand | -1.09 Million | 1.17 Million | 50.2 Thousand |
| Depreciation & Amortization | 121.42 Thousand | 114.98 Thousand | 83.51 Thousand | 97.62 Thousand | 85.64 Thousand | 135.64 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 964.51 Thousand | -1.56 Million | -2.67 Million | 5.01 Million | -1.46 Million | -572.6 Thousand |
| Other non-cash items | -645.23 Thousand | 1.45 Million | 2.85 Million | -4.82 Million | 1.63 Million | 1.27 Million |
| Investing Cash Flow | - | 35.53 Thousand | 1.69 Million | -1.94 Million | - | 30.8 Thousand |
| Investments in PPE | - | - | - | -1.94 Million | - | - |
| Acquisitions | - | 35.53 Thousand | 1.69 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 30.8 Thousand |
| Financing Cash Flow | - | - | - | - | - | 158.52 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 158.52 Thousand |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -475.97 Thousand | 908.39 Thousand | -2.74 Million | 1.82 Million | -1.22 Million | 484.62 Thousand |
| Accounts payables | 1.46 Million | -2.02 Million | 248.41 Thousand | 3.07 Million | -243.51 Thousand | -918.21 Thousand |
| Inventory | -18.82 Thousand | -110.32 Thousand | -194.43 Thousand | 113.94 Thousand | 7877.00 | -139.01 Thousand |
| Other working capital | -7561.00 | -337.44 Thousand | 12.38 Thousand | - | - | - |
| Cash at beginning of period | 193.46 Thousand | 160.77 Thousand | 750.34 Thousand | 132.6 Thousand | 363.7 Thousand | 129.62 Thousand |
| Cash at end of period | 22.67 Thousand | 193.46 Thousand | 160.77 Thousand | 750.34 Thousand | 132.6 Thousand | 363.7 Thousand |
| Capital Expenditure | - | - | - | -1.94 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -170.79 Thousand | 32.69 Thousand | -589.56 Thousand | 617.73 Thousand | -231.1 Thousand | 234.08 Thousand |
| Free Cash Flow | -139.62 Thousand | 1933.00 | -1.96 Million | 2.07 Million | -200.68 Thousand | 44.74 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.8 Million | -2.37 Million | -1.28 Million | -1.3 Million | 1.77 Million | -1.04 Million |
| Depreciation & Amortization | 58.57 Thousand | - | 28.29 Thousand | 121.42 Thousand | 29.34 Thousand | 34.5 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.31 Million | 1.74 Million | 1.13 Million | 964.51 Thousand | -820.1 Thousand | -90.78 Thousand |
| Other non-cash items | 7.1 Million | 1.13 Million | -1 Million | -645.23 Thousand | -119.07 Thousand | 1.21 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 1.56 Million | 435.25 Thousand | 992.56 Thousand | -475.97 Thousand | -1.11 Million | 252.8 Thousand |
| Accounts payables | -3.16 Million | 513.71 Thousand | -42.09 Thousand | 1.46 Million | 270.06 Thousand | -372.46 Thousand |
| Inventory | -110 Thousand | 388.74 Thousand | 190.32 Thousand | -18.82 Thousand | 20.45 Thousand | -19.8 Thousand |
| Other working capital | -600.39 Thousand | 405.17 Thousand | -4779.00 | -7561.00 | 6722.00 | 48.68 Thousand |
| Cash at beginning of period | 1.89 Million | 22.67 Thousand | 86.25 Thousand | 193.46 Thousand | 103.23 Thousand | 191.63 Thousand |
| Cash at end of period | 6.7 Million | 1.89 Million | 22.67 Thousand | 22.67 Thousand | 86.25 Thousand | 103.23 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 4.81 Million | 1.87 Million | -63.57 Thousand | -170.79 Thousand | -16.98 Thousand | -88.4 Thousand |
| Free Cash Flow | 4.81 Million | 1.84 Million | -32.4 Thousand | -139.62 Thousand | -16.98 Thousand | -94.35 Thousand |
002403
SUAC
PARNAXLAB
MINA
0430
600170